Ratings
0
Nobody has rated this yet. Be the first!
Works
3
Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis
Research highlights from the 2018 ERS International Congress: interstitial lung diseases
